Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

D Medical to sell holdings in subsidiary NextGen Biomed

D Medical Industries is set to sell its holdings in its publicly held subsidiary NextGen Biomed, as part of plans to focus on commercialization of its current and future products.

Through its subsidiaries, D Medical is engaged in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery.

D Medical products include durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient’s body, using its proprietary spring-based delivery technology.

It has also developed an infusion set for insulin pumps and is focusing its research and development efforts on the development of next generation insulin pumps and a device that will combine a continuous glucose monitoring system and an insulin pump on the same patch.